These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 30198422)

  • 1. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
    Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2020 Jun; 42(6):1010428320924524. PubMed ID: 32515296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer.
    Ali H; AbdelMageed M; Olsson L; Israelsson A; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2019 Jun; 41(6):1010428319858885. PubMed ID: 31250711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
    Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
    Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.
    AbdelMageed M; Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of the chemokine CXCL17 in colon cancer cells.
    Ohlsson L; Hammarström ML; Lindmark G; Hammarström S; Sitohy B
    Br J Cancer; 2016 Mar; 114(6):697-703. PubMed ID: 26889977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
    D'Cunha J; Corfits AL; Herndon JE; Kern JA; Kohman LJ; Patterson GA; Kratzke RA; Maddaus MA
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):484-91; discussion 491. PubMed ID: 11882819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer.
    Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2021; 43(1):209-223. PubMed ID: 34486997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of occult metastases in colon cancer.
    Merrie AE; van Rij AM; Dennett ER; Phillips LV; Yun K; McCall JL
    Dis Colon Rectum; 2003 Feb; 46(2):221-31. PubMed ID: 12576896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
    Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L
    Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer.
    Murono K; Kazama S; Yamaguchi H; Kawai K; Ishihara S; Sunami E; Kitayama J; Satoh Y; Kurihara M; Yatomi Y; Watanabe T
    Surgery; 2015 Feb; 157(2):322-30. PubMed ID: 25311262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR.
    Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
    Int J Colorectal Dis; 2009 Mar; 24(3):261-8. PubMed ID: 19119477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
    Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
    Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.
    AbdelMageed M; Ismail HTH; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
    Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
    Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.
    Sargent DJ; Shi Q; Gill S; Louvet C; Everson RB; Kellner U; Clancy TE; Pipas JM; Resnick MB; Meyers MO; Wu TT; Huntsman D; Validire P; Farooq U; Pavey ES; Beaudry G; Haince JF; Fradet Y
    Clin Cancer Res; 2014 Aug; 20(16):4361-9. PubMed ID: 24919572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
    Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
    Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
    Sargent DJ; Resnick MB; Meyers MO; Goldar-Najafi A; Clancy T; Gill S; Siemons GO; Shi Q; Bot BM; Wu TT; Beaudry G; Haince JF; Fradet Y
    Ann Surg Oncol; 2011 Nov; 18(12):3261-70. PubMed ID: 21533822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of occult tumor cells in lymph nodes from non-small cell lung cancer patients using reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA with the evaluation of its sensitivity.
    Maeda J; Inoue M; Okumura M; Ohta M; Minami M; Shiono H; Shintani Y; Matsuda H; Matsuura N
    Lung Cancer; 2006 May; 52(2):235-40. PubMed ID: 16510209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer.
    Raja S; Luketich JD; Kelly LA; Gooding WE; Finkelstein SD; Godfrey TE
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):475-82; discussion 482-3. PubMed ID: 11882818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.